Introducing Our Collaboration with Phoenix Biotechnology PAWs Division

Ramaekers Nutrition, a Unique Research and Development Company


Ramaekers Nutrition specializes in custom nutrition with a distinct focus on immunotherapy. Our approach to immunotherapy involves managing the viral load to ensure we have immune cells to train.

Dr. Ramaekers is collaborating with Phoenix Animal Biotechnology's PAWs division, a company renowned for its extensive research and development in addressing health challenges posed by enveloped viruses such as COVID-19, bovine respiratory disease, purrs in swine, and avian flu.


PAW Monthly Newsletter, Volumne 1, Page 2. Amish breeding colonies puppies.

These newborn puppies are from Amish breeding colonies that we're treating. Eight colonies have been treated so far, and the puppies are healthier than ever. They have virtually no gastrointestinal issues like Giardiasis, a very important protozoan infection of dogs and men commonly seen in breeding facilities. So far, our field studies have shown excellent results.

PAW Monthly Newsletter, Volumne 1, Page 3. Production Animals Field Report.

Deteriorating health, mortality, morbidity, and poor feed conversion are significant problems for livestock, poultry, and companion animals.

We are excited to report new data demonstrating that our products, even at very low doses, improve overall health and feed conversion and reduce mortality and morbidity.

Currently, we are treating 105 no-bid non-ruminating calves with the combination of Ramaekers Stress Pack and PAWs oleander (OLE) product. In addition, we are conducting a study on 50 head of high-risk calves (450 to 650 pounds) in southern Kansas.

We believe we will positively impact all production animals, potentially even poultry.


Immunotherapy & Antiviral Science

Dr. Ramaekers's studies aim to combine the power of his immunotherapy program with proven antiviral science.

Phoenix Biotechnology has made significant investments in human research and holds over 150 patents in this field, underscoring the potential of this antiviral technology.

Dedicated Research

Since mid-2022, Dr. Ramaekers has dedicated his research to studying his transfer factor, medical mushroom, and probiotic products. The focus has been on safety, tissue residue, and therapeutic dosage for cattle, swine, poultry, and companion animal diseases.

The results thus far have been nothing short of amazing, paving the way for the future of this all-organic antiviral immunotherapy research.

Early Studies

Ramaekers Nutrition always seeks nonantibiotic answers to all health challenges threatening our livestock and companion animals. We have found a significant piece of the puzzle in these early studies.

Field Trials

We welcome any interested parties to participate in our field trials (contact us).

Science Studies

For more information, please see these detailed science studies on this new viral innovation.

Connect with Us